Clinical Trials for Diffuse Midline Glioma (DMG)

Find clinical trials for diffuse midline glioma (dmg). Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

NCT ID: NCT06896110

This clinical trial is looking at a new treatment approach for patients with recurrent high-grade gliomas, which are aggressive types of brain tumors. The study is testing the combination of two me...

Enrolling by invitation

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

NCT ID: NCT04732065

This clinical trial is studying a new medication called ONC206 to see how well it works in treating specific types of brain tumors, including newly diagnosed and recurrent diffuse midline gliomas, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, San Francisco, California, United States +3 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions